BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32309278)

  • 1. Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of "Stealthy" Nanomaterials.
    Rampado R; Crotti S; Caliceti P; Pucciarelli S; Agostini M
    Front Bioeng Biotechnol; 2020; 8():166. PubMed ID: 32309278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the analysis of nanoparticle-protein coronas.
    Ovais M; Nethi SK; Ullah S; Ahmad I; Mukherjee S; Chen C
    Nanomedicine (Lond); 2020 Apr; 15(10):1037-1061. PubMed ID: 32248745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein corona and its effects on nanoparticle-based drug delivery systems.
    Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
    Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Singh N; Marets C; Boudon J; Millot N; Saviot L; Maurizi L
    Nanoscale Adv; 2021 Mar; 3(5):1209-1229. PubMed ID: 36132858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into Characterization Methods and Biomedical Applications of Nanoparticle-Protein Corona.
    Li Y; Lee JS
    Materials (Basel); 2020 Jul; 13(14):. PubMed ID: 32664362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of protein corona on the biological behavior of targeting nanomedicines.
    Farshbaf M; Valizadeh H; Panahi Y; Fatahi Y; Chen M; Zarebkohan A; Gao H
    Int J Pharm; 2022 Feb; 614():121458. PubMed ID: 35017025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of a protein corona influences the biological identity of nanomaterials.
    Nierenberg D; Khaled AR; Flores O
    Rep Pract Oncol Radiother; 2018; 23(4):300-308. PubMed ID: 30100819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective.
    Wang H; Lin Y; Nienhaus K; Nienhaus GU
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1500. PubMed ID: 29071798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy.
    Khan S; Sharifi M; Gleghorn JP; Babadaei MMN; Bloukh SH; Edis Z; Amin M; Bai Q; Ten Hagen TLM; Falahati M; Cho WC
    J Control Release; 2022 Aug; 348():127-147. PubMed ID: 35660636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona.
    Caracciolo G; Farokhzad OC; Mahmoudi M
    Trends Biotechnol; 2017 Mar; 35(3):257-264. PubMed ID: 27663778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a molecular understanding of nanoparticle-protein interactions.
    Treuel L; Nienhaus GU
    Biophys Rev; 2012 Jun; 4(2):137-147. PubMed ID: 28510093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.
    Corbo C; Molinaro R; Parodi A; Toledano Furman NE; Salvatore F; Tasciotti E
    Nanomedicine (Lond); 2016 Jan; 11(1):81-100. PubMed ID: 26653875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stealth effect of biomolecular corona on nanoparticle uptake by immune cells.
    Caracciolo G; Palchetti S; Colapicchioni V; Digiacomo L; Pozzi D; Capriotti AL; La Barbera G; Laganà A
    Langmuir; 2015 Oct; 31(39):10764-73. PubMed ID: 26378619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Link between Low-Fouling and Stealth: A Whole Blood Biomolecular Corona and Cellular Association Analysis on Nanoengineered Particles.
    Weiss ACG; Kelly HG; Faria M; Besford QA; Wheatley AK; Ang CS; Crampin EJ; Caruso F; Kent SJ
    ACS Nano; 2019 May; 13(5):4980-4991. PubMed ID: 30998312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protein corona magnetite nanoparticles derived from bread in vitro digestion on Caco-2 cells morphology and uptake.
    Di Silvio D; Rigby N; Bajka B; Mackie A; Baldelli Bombelli F
    Int J Biochem Cell Biol; 2016 Jun; 75():212-22. PubMed ID: 26520468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revising Protein Corona Characterization and Combining ITC and Nano-DSC to Understand the Interaction of Proteins With Porous Nanoparticles.
    Balmori A; Sandu R; Gheorghe D; Botea-Petcu A; Precupas A; Tanasescu S; Sánchez-García D; Borrós S
    Front Bioeng Biotechnol; 2021; 9():650281. PubMed ID: 34708023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.